Synapse loss, rather than the hallmark amyloid-b (Ab) plaques or tau-filled neurofibrillary tangles (NFT), is considered the most predictive pathological feature associated with cognitive status in the Alzheimer's disease (AD) brain. The role of Ab in synapse loss is well established, but despite data linking tau to synaptic function, the role of tau in synapse loss remains largely undetermined. Here we test the hypothesis that human mutant P301L tau overexpression in a mouse model (rTg4510) will lead to age-dependent synaptic loss and dysfunction. Using array tomography and two methods of quantification (automated, threshold-based counting and a manual stereology-based technique) we demonstrate that overall synapse density is maintained in the neuropil, implicating synapse loss commensurate with the cortical atrophy known to occur in this model. Multiphoton in vivo imag-ing reveals close to 30% loss of apical dendritic spines of individual pyramidal neurons, suggesting these cells may be particularly vulnerable to tau-induced degeneration. Postmortem, we confirm the presence of tau in dendritic spines of rTg4510-YFP mouse brain by array tomography. These data implicate tau-induced loss of a subset of synapses that may be accompanied by compensatory increases in other synaptic subtypes, thereby preserving overall synapse density. Biochemical fractionation of synaptosomes from rTg4510 brain demonstrates a significant decrease in expression of several synaptic proteins, suggesting a functional deficit of remaining synapses in the rTg4510 brain. Together, these data show morphological and biochemical synaptic consequences in response to tau overexpression in the rTg4510 mouse model.
INDEXING TERMS: Alzheimer's disease; tauopathy; hyperphosphorylated tau; array tomography Alzheimer's disease (AD) brain is defined not only by the hallmark protein aggregates of plaques and neurofibrillary tangles (NFT) but also by marked synapse and neuronal loss. The extracellular plaques are deposits of amyloid-b (Ab), the peptide largely considered the initiator of the disease (Hardy and Selkoe, 2002) , and yet amyloid burden does not correlate well with synapse and neuronal loss or severity of AD (Arriagada et al., 1992; Giannakopoulos et al., 2003; Ingelsson et al., 2004) . Although intracellular NFT composed primarily of aberrantly phosphorylated and misfolded tau protein correlate more closely than plaque load with neuronal loss and cognitive deficits of AD, synapse loss is the most predictive of cognitive status (Terry et al., 1991; Gomez-Isla et al., 1997; Selkoe, 2002; Giannakopoulos et al., 2003; Ingelsson et al., 2004) . Soluble oligomeric forms of Ab are strongly implicated in synapse loss early in the disease process (Selkoe, 2008; Koffie et al., 2009 Koffie et al., , 2012 but the contribution of tau is less well understood. Here we use a reversible mouse model of tauopathy (rTg4510), in combination with array tomography, in vivo multiphoton imaging, and synaptosome biochemical analysis to test the hypothesis that overexpression of human mutant tau in a mouse model will lead to age-dependent loss of synapse density and function in the cortex.
Tau is a member of the microtubule-associated protein family, residing primarily in axons, playing an intrinsic role in microtubule stabilization and neuronal transport. Disruptions to normal tau function via hyperphosphorylation, mislocalization, misfolding, and fibrilization occur in AD, and are thought to impede transport and result in distal sites devoid of essential machinery (Stamer et al., 2002; Coleman and Yao, 2003; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007; Cuchillo-Ibanez et al., 2008; Dixit et al., 2008; Morfini et al., 2009; Zempel et al., 2010) , ultimately leading to axonal and dendritic ''dying back'' and neuronal death (Coleman and Yao, 2003; Yoshiyama et al., 2007; Morfini et al., 2009 ). In addition, recent studies place tau both physiologically and pathologically in dendritic spines, suggesting that tau may have a more direct role in dendritic degeneration as well (Hoover et al., 2010; Ittner et al., 2010; Kremer et al., 2011; Tai et al., 2012; .
Experimental results of whether changes to tau are related to synaptic deficits have been extremely diverse, with reports of pathological tau causing synaptic loss or dysfunction, maintenance, and homeostasis and even compensatory increases in synaptic density and function. A complication in interpreting these results arises from differing tau models both in vitro and in vivo, in which isoforms of human wildtype, mutant, pro-or antiaggregant, fluorescent protein fused, and even endogenous tau are used for drawing broad conclusions about repercussions of pathological changes in tau (see Table 1 for details).
In vitro studies with changes to or overexpression of tau have shown substantial disruption of organelle transport, calcium changes, and dendritic spine loss (Hall et al., 2000; Thies and Mandelkow, 2007; Stoothoff et al., 2009; Zempel et al., 2010; . Transfection of lamprey central neurons with the shortest isoform of human tau led to filament formation associated with dendritic degeneration and synapse loss, resultant from trafficking impairments (Hall et al., 2000) . Similar findings emerged from overexpression of the longest human tau isoform in mouse primary hippocampal neurons in which missorting of tau and transport deficits preceded synaptic degeneration (Thies and Mandelkow, 2007; Stoothoff et al., 2009) . Even without introducing exogenous tau, abnormal phosphorylation and missorting contribute to disturbance of organelle transport, calcium levels, and synapse loss in response to exogenous Ab application (Zempel et al., 2010; .
Several animal models, with transgenes for overexpression of human mutant tau known to lead to dementia such as P301L or P301S, introduction of mutant tau via adeno-associated virus or tau mutant mice expressing a proaggregating variant of tau have all established distinct spine loss and/or depletion of synaptic proteins concomitant with tau overexpression (Eckermann et al., 2007; Mocanu et al., 2008; Dubey et al., 2008; Bittner et al., 2010; Rocher et al., 2010; Sydow et al., 2011a,b; Jaworski et al., 2011) . In other tau models, dysregulation of synaptic proteins has also been reported, with expression differentially influenced by tau (David et al., 2005; Yoshiyama et al., 2007; Mocanu et al., 2008; Hoover et al., 2010; Lasagna-Reeves et al., 2011; Alldred et al., 2012) . Even with no evident change in structural components such as synaptic vesicle-related proteins or postsynaptic density scaffolding protein PSD95, alterations in N-methyl-D-aspartate (NMDA) and a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor subunit representation may be evident, implying functional deficits since these are imperative to processes of neuronal function, synaptic transmission, and learning and memory (Sabatini et al., 2001; Yoshiyama et al., 2007; Hoover et al., 2010) . AMPA receptors appear particularly vulnerable to tau-induced deficits as subunits GluR1, 2, and 3 are reportedly diminished in several models (Yoshiyama et al., 2007; Hoover et al., 2010; Morris et al., 2011; . This change in AMPA receptor content has been likened to long-term depression, a form of synaptic plasticity that can lead to regression of dendritic spines (Berridge, 2011; Crimins et al., 2011; D'Amelio et al., 2011; Huang and Mucke, 2012; Spires-Jones and Knafo, 2012; . Contrary to these findings, however, others have reported no evidence of change in receptor composition, pre-and/or postsynaptic markers and have, therefore, postulated that synapse loss does not occur in conjunction with alterations to the same isoforms or mutations of tau that are associated with deficits in other studies (Shahani et al., 2006; Tackenberg and Brandt, 2009; Hoover et al., 2010; Kimura et al., 2010; Kremer et al., 2011) .
Yet another series of studies have proposed not only that tau does not induce synapse loss, but rather that compensatory mechanisms in remaining neurons may be at play in tau models, leading to increases in synaptic proteins or synapses themselves, particularly at early stages (David et al., 2005; Boekhoorn et al., 2006; Amadoro et al., 2010; Bittner et al., 2010; Dickstein et al., 2010; Kimura et al., 2010; Kremer et al., 2011; Crimins et al., 2011) . In human wildtype or P301L tau overexpressing mice, formation of new synapses or changes in spine morphology provide potential mechanisms for maintenance of normal network activity, even at advanced stages of tauopathy (Dickstein et al., 2010; Crimins et al., 2011) . Even in human AD brain, compensatory increases in synapse size and protein content have been suggested to counteract declines in synapse density (DeKosky et al., 1996; Gylys et al., 2004; Leuba et al., 2008; Amadoro et al., 2010) , and there is clear evidence of neural system plasticity (Geddes et al., 1985;  Geddes and Cotman, 1986; Hyman et al., 1987; Scheff et al., 1990; Scheff and Price, 2003) .
In the present study we reconcile some of these previously disparate findings by addressing the effects of pathological changes to tau on synapses using two high-resolution imaging techniques, array tomography and twophoton in vivo microscopy, alongside biochemical fractionation experiments in rTg4510 mice. These mice overexpress human mutant P301L tau and suffer progressive neuronal loss and cognitive deficits in conjunction with accumulation of NFT. We observe maintenance of total synapse density but loss of dendritic spines of cortical pyramidal neurons, indicating that synapse loss parallels cortical atrophy known to occur in this mouse model (Spires et al., 2006) and that spines of pyramidal neurons may be particularly vulnerable to tau-induced dendritic degeneration. Compensatory increases in other synapse subtypes may contribute to preservation of overall synapse density. We confirm the presence of tau in dendritic spines of rTg4510-YFP mice, postmortem, indicating a potentially direct role of tau in dendritic spine collapse. However, presence of misfolded tau, detected by the conformational antibody Alz50, which persists in NFT, does not appear to impact linear synaptic densities, arguing against aggregates of tau as being locally toxic. Biochemical data indicate that remaining synapses are depleted of synaptic proteins, thereby revealing likely synaptic dysfunction. Taken together, our data suggest a morphological and functional synaptic deficit in rTg4510 tau overexpressing mice.
MATERIALS AND METHODS Animals
The rTg4510 mouse line used for these experiments is a well-characterized model of tauopathy (Santacruz et al., 2005; Spires et al., 2006; de Calignon, 2010; Fox et al., 2011; Kopeikina et al., 2011) . These bigenic mice have P301L human mutant four-repeat tau downstream of a tetracycline-operon-responsive element (TRE) on the responder transgene, and a tet-off open reading frame downstream of a Ca 2þ calmodulin kinase II promotor within the activator transgene that lead to overexpression of human mutant tau in forebrain structures when both responder and activator are present. Littermate animals with either only the activator or responder transgene, which do not overexpress tau, were used as controls.
A second line of rTg4510-YFP mice was used for array tomography and in vivo imaging experiments to allow for visualization of dendritic spines. To generate these mice, rTg4510 mice were crossed with transgenic mice expressing yellow fluorescent protein (YFP) driven by the Thy1 promotor (eYFP-H; Jackson Laboratories, Bar Har-bor, ME), yielding rTg4510 mice that overexpress P301L human mutant tau in the forebrain with a subset of these neurons also expressing YFP for enhanced visualization.
Institutional guidelines and those of the National Institutes of Health (NIH) were implemented for all animal housing and treatment protocols.
Array tomography
Preparation of tissue, immunohistochemical and microscopy techniques, and image analysis methods related to array tomography have been described elsewhere (Micheva and Smith, 2007; Koffie et al., 2009 Koffie et al., , 2012 Micheva et al., 2010; Kopeikina et al., 2011; de Calignon et al., 2012) . Immediately following euthanasia by CO 2 inhalation, small blocks of somatosensory cortex were immersion fixed for 3 hours at room temperature (RT) in 4% paraformaldehyde (PFA) and 2.5% sucrose in phosphate-buffered saline solution (PBS), pH 7.4. A graded series of ethanols was used to dehydrate tissue into LRWhite resin (Electron Microscopy Sciences, Fort Washington, PA), at which point tissue was embedded in gelatin capsules and polymerized at 53 C for 24 hours. Gelatin capsules were then removed and blocks cut with a Jumbo Histo Diamond Knife (Diatome, Fort Washington, PA) into ribbons of 7-30 ultrathin 70-nm consecutive sections, which were mounted on coverslips (Fisher Scientific, Pittsburgh, PA: 12-544-E; No. 1.5; 0.16-0.19 lm thick).
Immunostaining for analysis of synapse density was performed on tissue from rTg4510 and control mice at 5.5 and 8.5 months of age (n ¼ 4 per group, total 16 mice). A solution of 50 mM glycine in Tris buffered saline (TBS) was used to wash ribbons, followed with a blocking solution of 0.05% Tween and 0.1% bovine serum albumin (BSA) in Tris buffered saline. Primary antibodies (Table 2) mouse IgM anti-Alz50, mouse IgG anti-tubulin (Sigma, St. Louis, MO), goat anti-PSD95 (Abcam, Cambridge, MA), and rabbit anti-Synapsin I (Millipore, Bedford, MA) were diluted in block buffer at 1:100, applied to ribbons for 2 hours, then rinsed with TBS. Fluorescent secondary antibodies AMCA-conjugated donkey antimouse IgM, donkey antigoat Alexa-Fluor 488, donkey antirabbit Cy3 (Jackson ImmunoResearch, West Grove, PA), and chicken antimouse IgG Alexa-Fluor 647 (Invitrogen, La Jolla, CA) were diluted at 1:500 in block buffer and incubated on ribbons for 30 minutes. Prior to imaging, coverslips were then inverted onto a slide in mounting solution with or without nuclear stain. Areas of interest, containing nuclei or Alz50-positive cells within layers II/III of the somatosensory cortex, were imaged on 7-32 serial sections. Images of 1,024 Â 1,024 pixels were collected with a Zeiss Axioplan LSM510 confocal/multiphoton microscope (63Â numerical aperture Plan Apochromatic oil objective). Tile- scan images were collected on a Zeiss Axio Imager Z epifluorescence microscope equipped with AxioVision software and modified for automated acquisition of array tomography images.
To determine human tau localization within dendritic spines of rTg4510-YFP neurons, tissue of somatosensory cortex was similarly processed and stained for YFP with rabbit anti-GFP (Abcam), mouse HT7 for human tau (Thermo Scientific, Pittsburgh, PA) or mouse PHF-1 (generous gift of Peter Davies, Albert Einstein College of Medicine) for pathologically phosphorylated tau, and counterstained with DAPI. Immunostainings in which secondaries were applied without primaries served as controls for all array tomography experiments.
Open source software from the NIH (ImageJ) was used for image viewing and analysis. Images from each ribbon were opened sequentially, converted to a stack, and aligned with the MultiStackReg and StackReg plugins (courtesy of B. Busse at Stanford University and Thevenaz et al., 1998) . Crop boxes (10.01 Â 10.01 lm) were selected so as to exclude neuronal cell bodies or other obscuring features, realigned, and recropped to exclude empty space created by realignment. For automated image analysis, crops of interest (synapsin and PSD95) were automatically thresholded with the MaxEntropy ImageJ option and run through an automated, thresholdbased detection program that counts puncta appearing in more than one consecutive section and reports dimensions of each (WaterShed program provided by B. Busse, S. Smith, and K. Micheva, Stanford University). Density was calculated based on the output of the watershed program and the volume sampled within the crop box. Linear spine density (number of spines per micrometer) along the length of a small subset of tubulin-only-filled or Alz50 (tau) positive dendrites (n ¼ 14) was manually calculated from the synapsin and PSD95 watershed output files associated with a dendrite of interest. Two cortical blocks from the somatosensory cortex from each rTg4510 and control mouse were imaged, yielding close to 30,000 preand postsynaptic elements counted. The output of this automated analysis was then utilized in combination with a MatLab (MathWorks, Natick, MA) script to determine colocalization density of synapsin and PSD95 puncta within 0.5 lm of one another within each crop box.
In order to confirm the accuracy of the thresholdbased detection program, a modified physical disector analysis was also performed (Gundersen et al., 1988; West et al., 1988) . In short, all puncta appearing in a single section were marked manually. New puncta appearing on the following section were then identified. Those new puncta confirmed to still be present in the subsequent (third) section were counted (see Fig. 4 ), thereby combining traditional two serial section physical disector used in electron microscopy with the array tomography analysis principle of only counting puncta present in at least two sections, as puncta present in only one section are too thin to be synapses and likely represent staining noise. Three such physical disectors were applied to each stack of images, ensuring that the same sections were not reused, in order to count at least 100 new puncta per animal.
Tissue processing and immunohistochemistry
Mice were euthanized by CO 2 inhalation (one 9-monthold rTg4510 and one 9-month-old rTg4510-YFP) and brains removed and drop fixed in 4% PFA in PBS containing 15% glycerol cryoprotectant. Following 2 days in fixative, one hemisphere per animal was sectioned coronally on a freezing microtome to 50 lm. Sections were washed with TBS, permeabilized with 0.5% Triton-X in TBS for 20 minutes, blocked for 1 hour with 5% normal goat serum (NGS) in TBS, then immunostained with rabbit anti-GFP (Abcam) and mouse PHF1 (1:1,000 with 1% NGS in TBS for both) with secondaries goat antirabbit Alexa-Fluor 488 and goat antimouse Cy3 (1:500 for both) then counterstained with DAPI. Images were collected on a Zeiss Axio Imager Z epifluorescence microscope equipped with Axio-Vision software and a 10Â objective.
Cranial window implantation and multiphoton in vivo imaging
rTg4510-YFP and control mice (n ¼ 4 per group; 9-10 months of age) received cranial windows for in vivo imaging of dendritic spines (Bacskai et al., 2002; Klunk et al., 2002; Kuchibhotla et al., 2008; Spires-Jones et al., 2008) . Mice were anesthetized with isoflurane, secured in a stereotax, and skin on the top of the head removed following sterilization and injection of a local anesthetic. Using a high-speed drill, a 6-mm circular craniotomy was established, the brain washed with PBS, and covered with an 8 mm glass coverslip. The coverslip was secured with a dental cement-Krazy glue mixture and mice given 3 weeks recovery to account for any consequences of surgery.
For imaging, mice were again anesthetized with isoflurane and secured in a stereotax. A restraining ring of low-melting point wax was applied to the coverslip and filled with distilled water for the Olympus 20Â 0.95N water immersion objective. The stereotax was then placed on the stage of an Olympus BX61WI upright microscope equipped with pre-chirp optics, fast AOM, Olympus Fluoview 1000MPE software, and a series of photomultiplier tube detectors (Hamamatsu, Ichinocho, Japan). A MaiTai titanium/sapphire laser (Spectra-Physics, Fremont, CA) generated two-photon fluorescence with 800 nm excitation. Images were collected with z-axis resolution of 0.8 lm, scanning speed of 8 ls/
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Spine density analysis was performed with ImageJ and NeuronStudio (Mt. Sinai School of Medicine, Computational Neurobiology and Imaging Center). Dendrites of at least 20 lm in length and a minimum of three spines along that length were chosen for analysis. Images were opened in NeuronStudio and run through a median blur filter. The dendritic segment and associated spines were selected semiautomatically and confirmed manually by comparison to the original image stack viewed in ImageJ. Spine densities were calculated as the number of spines per micrometer. At the end of in vivo imaging experiments, rTg4510-YFP mice were also prepared for array tomography as described previously.
Western blotting
rTg4510 and control mice (n ¼ 4 per group; 12 months of age) were euthanized with CO 2 and the cortical tissue dissected, snap-frozen in liquid nitrogen, and stored at À80 C. After thawing, each hemi-cortex was gently ground in a Potter-Elvehjem homogenizer with 1.5 mL icecold buffer A (20 mM HEPES pH 7.5, 0.3 M DTT), supplemented with 2 mM DTT, protease inhibitors (Roche Complete tablet), and phosphatase inhibitors (Sigma cocktail 2 and 3). The homogenate was passed through two layers of 80-lm nylon filters (Millipore) to remove tissue debris, and a 200 lL aliquot was saved. The saved aliquot was mixed with 200 lL water and 70 lL 10% SDS, passed through a 27G needle, and boiled for 5 minutes to prepare total extract. The rest of the homogenate was centrifuged at 500g for 3 minutes to remove nuclei. This was followed by centrifugation at 12,000g for 15 minutes to pellet synaptic terminals. The pellet was washed once with buffer A and centrifuged again, yielding the crude synaptosome pellet. Supernatant from the first 12,000g centrifugation step was clarified by centrifugation at 100,000g for 1 hour to obtain the cytosol fraction. Cytosolic extract was prepared by adding 1.5% SDS and boiling for 5 minutes. Synaptosome pellets were extracted with 0.5 mL buffer B (50 mM Tris pH 7.5, 1.5% SDS, 2 mM DTT) and boiled for 5 minutes. Protein concentration was determined by BCA assay (Pierce, Rockford, IL).
For standard sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; Invitrogen), protein lysates ($20 lg/lane) were boiled in sample buffer containing reducing agent and lithium dodecyl sulfate (Invitrogen), then resolved on NuPage Bis-Tris 4-12% gels and transferred to nitrocellulose membranes (Whatman, Clifton, NJ). Membranes were blocked with Odyssey Block buffer (Li-Cor Biosciences, Lincoln, NE) and incubated with a subset of the following primary antibodies (Table 2) ; b-actin (Sigma; 1:10,000), GluR1 (Millipore; 1:500), GluR2 (Chemicon, Temecula, CA; 1:500), NMDAR1 (Millipore; 1:500), NMDAR2A (Upstate/Millipore; 1:500), PSD95 (Cell Signaling, Beverly, MA; 1:5,000), and Synapsin 1 (Millipore; 1:5,000). Secondary antibodies antimouse or antirabbit IgG conjugated to IRDye 680 or 800 (Li-Cor Biosciences; 1:5,000 and 1:10,000, respectively) were used for detection on an infrared imaging system (Li-Cor Odyssey). Band intensities were measured by densitometry using ImageJ and normalized to b-actin. Data presented are an average of three experiments in which three animals per condition are represented.
Antibody characterization
Antibody information is summarized in Table 2 . The antibodies to tau protein used in these experiments have been widely used and previously characterized. The monoclonal Alz50 mouse IgM antibody was a generous gift of Peter Davies at Albert Einstein College of Medicine, and was first prepared against homogenates of brain tissue from temporal cortex of human AD patients (Wolozin et al., 1986) . The Alz50 epitope was later determined to be two discontinuous segments of tau protein (AA7-9 and AA312-342), representative of an intramolecular conformational change (Carmel et al., 1996; Jicha et al., 1997) . In western blot, Alz50 recognizes a 64-68 kD species highly enriched in the AD brain and largely undetected in control brain (Wolozin et al., 1986) . Immunohistochemistry and array tomography with Alz50 in both mouse and human brain tissue identifies pre-tangles, a subpopulation of mature NFTs, and neuropil threads and demonstrates no staining in control mouse and minimal staining in control human brain (Wolozin et al., 1986; Hyman et al., 1988; Kopeikina et al., 2011) . Monoclonal mouse IgG antibody PHF1 was also received as a gift from Peter Davies, and was first prepared against purified paired helical filaments of human AD brain (Greenberg and Davies, 1990; Greenberg et al., 1992; Davies, 2000) . PHF1 is a phosphorylation-dependent antibody with the epitope consisting of pSer396/pS404, which is considered a late-stage phosphorylation in tau pathology. Western blots of mouse or human tissue with PHF1 reveal a band in the 64-68 kD range and immunohistochemistry shows fibrillar pathology of both NFT and neuropil threads with little to no reactivity in control tissues (Polydoro et al., 2009; Fox et al., 2011; Tai et al., 2012; de Calignon et al., 2012) . The third tau antibody used was human tau specific HT7 (Thermo Scientific), a mouse monoclonal antibody raised to purified human tau (AA159-163) that recognizes 55-64 kD species of human tau in western blots (Eckermann et al., 2007; Kremer et al., 2011; de Calignon et al., 2012) . In transgenic mouse tissue, HT7 recognizes human tau overexpression, including NFT and neuropil threads, and yields no staining in control animals (de Calignon et al., 2012) .
Antibodies for synaptic proteins PSD95 (Abcam) and Synapsin I (Millipore) have been used for array tomography in several previous studies (Koffie et al., 2009 (Koffie et al., , 2012 Micheva et al., 2010) . Polyclonal PSD95 was raised in goats to a synthetic peptide consisting of AA1-100 of mouse postsynaptic scaffolding protein postsynaptic density 95. Immunohistochemistry with PSD95 shows postsynaptic elements that in control tissue show 90% colocalization with presynaptic elements (Koffie et al., 2009 ). These presynaptic elements can be identified with rabbit polyclonal antibody for vesicle tethering protein Synapsin 1. This antibody was raised against a mix of Synapsin Ia and Ib purified from bovine brain. Western blot analyses show bands at 77 and 80 kD, while immunohistochemistry shows presynaptic elements (Koffie et al., 2009 (Koffie et al., , 2012 Micheva et al., 2010; de Calignon et al., 2012) . A second PSD95 polyclonal antibody (Cell Signaling) was used for western blot experiments. This antibody was raised in rabbits against a synthetic peptide of human PSD95 and recognizes a 95-kD band in homogenates of human and mouse brain and is enriched in synaptosome fractions . Monoclonal rat GluR1 (Millipore) was generated with recombinant GluR1 and recognizes this subunit of postsynaptic AMPA receptors in immunostains, and appears as monomers (106 kD) and dimers (200 kD) in western blot. Monoclonal mouse GluR2 raised against recombinant GluR2 (AA175-430) recognizes another subunit of AMPA receptors and has been shown to colocalize with other postsynaptic elements and to be in close proximity to presynaptic elements in array tomographic immunostains (Micheva et al., 2010) . In western blot analyses, GluR2 reveals a band at 102 kD. The NMDAR1 mouse monoclonal antibody (Millipore) identifies the NR1 subunit of postsynaptic NMDA receptors, which is seen on western blot at 130 kD. This antibody was raised against a his-tagged peptide of residues 834-938 of rat NR1. Similarly, the NMDAR2A rabbit polyclonal antibody (Upstate/Millipore) was raised against a his-tagged mouse NR2A fragment (residues 1265-1464) and runs at 170 kD in western blot. This antibody recognizes another subunit (NR2) of the postsynaptic NMDA receptor.
The immunogen for the rabbit polyclonal GFP antibody (Abcam) was highly purified recombinant GFP made in E. coli, resulting in an antibody reactive to all variants of Aequorea victoria GFP such as GFP, YFP, CFP, RFP, and eGFP. In western blot this antibody detects a band at $27 kD, while in immunostains the antibody detects this family of fluorescent proteins. In our array tomography stains of YFP-4510 mice this antibody reveals YFP-positive neurons in transgenic tissue, with no staining evident in control animals.
A mouse monoclonal b-actin antibody (Sigma) served as the loading control for western blot experiments. This antibody recognizes an N-terminal epitope of the b-isoform of the cytoskeletal protein actin due to its preparation from an immunogen derived from a slightly modified N-terminal peptide of b-actin conjugated to KLH. Western blot of mouse or human brain tissue reveals a band at 42 kD (de Calignon et al., 2012; Tai et al., 2012) .
Tubulin, another cytoskeletal element, was distinguished with a mouse monoclonal acetylated-tubulin antibody (Sigma). This antibody was raised to acetylated a-tubulin from the outer arm of sea urchin sperm axonemes, and recognizes an epitope on a-tubulin found in the majority of species due to homology. In western blot this antibody reveals a band at 50-55 kD and in immunostain shows neuronal cell bodies and processes (Kopeikina et al., 2011) .
Statistics
Synapse density measurements were recorded for each individual crop box for both synapsin and PSD95, then grouped by age and genotype. No statistically significant differences between animals of each group were identified by analysis of variance (ANOVA), allowing us to combine all crops for each genotype and age rather than using an average for each animal. Colocalization density of synapsin and PSD95 puncta within 0.5 lm of one another was similarly recorded for each crop box. Each of these crop boxes then had three physical disectors applied, then averaged, for manual confirmation of synapse density, again grouped by age and genotype. Normality of data was assessed with a Shapiro-Wilks test. For data lacking normal distribution, Mann-Whitney U-tests were applied, while one-way ANOVA or Student's t-test were applied for normally distributed datasets. Significance was determined as a P-value of less than 0.05. Nonnormally distributed data are presented as boxplots, which display the median value (line inside the box), upper quartile (top of the box), lower quartile (bottom of the box), 90th percentile (top whisker), 10th percentile (bottom whisker), with all values below the 10th and above the 90th percentile (potential outliers) shown as dots. Normally distributed data are shown in bar graphs as mean and standard deviation unless otherwise noted.
RESULTS
Overall synapse density in the neuropil is maintained in rTg4510 mice Array tomography (Fig. 1 ) was used to quantify synaptic density in two age groups of rTg4510, prior to significant neuronal loss (5.5 months) and following significant
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The Journal of Comparative Neurology | Research in Systems Neuroscience Figure 1 . Array tomography method. A tile-scan image, taken with a 10Â objective, of a ribbon of 70-nm sections (s1-25 in A) of rTg4510-YFP brain with YFP shown in green, PHF1 (neurofibrillary tangles) in magenta, and DAPI (nuclei) in gray. The area outlined in (A) is enlarged in (B), demonstrating a higher-resolution view of a segment of sections 17 and 18. YFP and PHF1 are shown to colocalize in a subset of cells (white). The area outlined in (B) was imaged with the 63Â objective to yield a higher magnification image shown in (C). The 10 Â 10 lm crop box shown in (C) serves as an example of the crop boxes used for synapse density analyses and is shown at higher magnification in (D), with the arrow denoting the presence of a dendritic spine. Scale bars ¼ 1,000 lm in A; 100 lm in B; 10 lm in C; 1 lm in D. neuronal loss (8.5 months), and control mice to determine whether tauopathy in this model is associated with age-dependent synaptic loss and whether this loss pre-cedes or parallels the neuronal loss evident in this model (Spires et al., 2006) . A hybrid of conventional confocal and electron microscopy techniques, array tomography 
The Journal of Comparative Neurology | Research in Systems Neuroscience allows rapid and automated quantification of structures too small to be properly identified or localized with traditional confocal microscopy methods. Ultrathin sections of tissue, allowing for a z-axis resolution of $70 nm, were stained with tubulin, Alz50 (an antibody directed at a conformational state of tau also seen in NFT), and reliable synaptic markers synapsin I and PSD95 for identification of pre-and postsynaptic elements, respectively, and are shown in Figure 2 (Micheva and Smith, 2007; Koffie et al., 2009 Koffie et al., , 2012 Micheva et al., 2010; Kopeikina et al., 2011; Spires-Jones and Knafo, 2012) .
At 5.5 months of age the somatosensory cortex of rTg4510 mice has not yet suffered significant neuronal loss, although a few NFT have begun to accumulate (Spires et al., 2006) . When applying an automated, threshold-based detection program that excludes puncta too small to be synapses, no significant changes were identified in synapsin I or PSD95 density between Figure 3 . Synapse density in the neuropil is maintained in rTg4510 mice. Automated threshold-based quantification of synapse density obtained by array tomography for 5.5-month (A) and 8.5-month-old (B) rTg4510 and control mice is shown in the box and whisker plots of the top row. No statistically significant change in synapse density is identified for either age group with this method. Manual stereology based physical disector quantification of synapse density is shown in the box and whisker plots of the second row (C,D) and confirm the findings with the automated analysis. This more sensitive analysis reveals slightly greater absolute values for synapse density altogether and a significant increase in PSD95 density in rTg4510 mice at 5.5 months of age that may represent compensatory responses (C). The last box and whisker plot (E) shows colocalization density of synapsin and PSD95 within 0.5 lm of one another for 5.5-and 8.5-month-old rTg4510 and control mice obtained following the automated assessment. No statistically significant differences in colocalization was detected. (*P < 0.5). 5.5-month rTg4510 and control mice (Fig. 3A) . This automated analysis method allows quantification of tens of thousands of synaptic puncta with relative ease compared to manual methods of counting synapses. Automated analysis also provides the opportunity for additional data to be extracted from the same raw files. Here we applied a MatLab script to quantify colocalization density of synapsin and PSD95 puncta within 0.5 lm of one another (Fig. 3E) . No difference in colocalization density was detected with this method, suggesting that synaptic partners remain intact rather than orphaning pre-or postsynaptic elements. To confirm the validity of the automated analysis paradigm, we also applied a traditional stereology approach of the physical disector method (Fig. 4) to the array tomography data (Gundersen et al., 1988; West et al., 1988) . This labor-intensive method of quantification does not rely on selecting a threshold, but rather uses raw images and counts ''new'' puncta that appear in sequential serial sections. We modified the physical disector method, which is traditionally carried out on electron micrographs where synapses are defined by ultrastructure instead of immunolabeling, to include a third serial section and only ''new'' puncta, which remain present in the third section, were counted as synapses. This excludes puncta too thin to be synapses that are likely noise from immunostaining (nonspecific secondary staining). This stereological, nonthreshold-based approach is more sensitive than the automated threshold-based detection and generates slightly higher absolute synaptic densities. With physical disector counts we confirm maintenance of synaptic density in rTg4510 cortex (Fig. 3C ) and with this more sensitive method we were in fact able to detect a small ($14%) but statistically significant elevation of PSD95 in 5.5-month-old rTg4510 mice when compared to controls (P < 0.05).
Substantial tauopathy is evident in the somatosensory cortex of rTg4510 mice at 8.5 months of age, when significant accumulation of NFT, neuronal loss, and cortical atrophy occur (Spires et al., 2006) . Even in the face of marked neurodegeneration, synaptic density based on synapsin I and PSD95 staining remained stable in 8.5month-old rTg4510 mice when compared to controls (Fig. 3B,D) , regardless of method of analysis (MaxEntropy or physical disector). Colocalization density following automated analysis also demonstrates a preservation of pairing of synapsin and PSD95 in the 8.5-month rTg4510 mice as compared to controls (Fig. 3E) . These findings suggest that synapse density in the neuropil is maintained while the volume of the neuropil significantly decreases (Spires et al., 2006) , resulting in a net loss of synapses (total number of synapses ¼ synapse density * neuropil volume). These synapses are likely lost with equal preference for pre-and postsynaptic elements, regardless of the presence of aggregated misfolded tau, as colocalization and neuropil thread-associated linear spine densities are maintained. This suggests that neuronal loss and neuropil remodeling proceed in tandem in this model. In addition, Mann-Whitney U analysis of linear synapse density demonstrated no statistically significant difference between neuropil thread containing (Alz50þ) versus tubulin-only filled processes in 8.5-month-old rTg4510 brain, indicating that fibrillar tau in dendrites is not causing local loss of synapses in this model.
In vivo imaging demonstrates loss of dendritic spine density in rTg4510 mice
By contrast to the results noted above using array tomography, Rocher et al. (2010) found loss of apical dendritic spines in biocytin-filled neurons in frontal cortex of 8.5-month-old rTg4510 mice. Since array tomography detects all synapses, we next examined dendritic spine density of apical dendrites of pyramidal neurons to determine whether these spines are particularly vulnerable to tau-induced toxicity. To enable visualization of dendritic Figure 5 . rTg4510 and rTg4510-YFP show similar degeneration and tau pathology at 9 months of age. Tile-scans of coronal sections of 9-monthold rTg4510 (A,C) and rTg4510-YFP (B,D-F) cortex and hippocampus demonstrate similar loss of neurons in CA1 (asterisks) and tangle pathology based on DAPI (gray), PHF1 (magenta), and YFP (green) immunostaining in 50-lm floating sections. Higher-resolution images (C,D) demonstrate similar levels of tau pathology in the cortex of both transgenic mouse lines. In the rTg4510-YFP cortex, some colocalization of YFP and tau pathology occurs (white) in cell bodies (arrows, E) and neuropil threads (arrowhead, F). Scale bars ¼ 1,000 lm in A,B; 100 lm in C,D; 50 lm in E; 10 lm in F. spines in vivo, cranial windows were implanted over the somatosensory cortex of 9-10-month-old rTg4510-YFP mice, which overexpress human mutant tau and also have a subset of neurons filled with YFP, driven by a separate promoter (Thy1) from the human mutant tau. To ensure that introduction of YFP did not hinder accumulation of tau pathology, side-by-side comparison of hippocampus and cortex of 9-month-old rTg4510 and rTg4510-YFP was performed with immunostaining for YFP, PHF1, and DAPI, as shown in Figure 5 . Both transgenic lines demonstrate similar thinning of the CA1 subregion of the hippocampus and accumulation of tangles (PHF1þ) in the cortex with significant colabeling for YFP and PHF1. YFP is largely expressed in layer V pyramidal neurons in cortex, while tau is present in both layer V and layer II-III neurons (Fig. 5) . Dendritic spines were imaged in vivo with multiphoton microscopy and quanti-fied in rTg4510-YFP and control animals ( Fig. 6) . A oneway ANOVA shows significant loss of dendritic spine density (close to 30%) in aged rTg4510-YFP mice as compared to control (F (1,60) ¼ 19.8; P < 0.0001). These data argue that while synaptic density may remain unchanged, synapses are distinctly lost along apical dendrites of vulnerable neurons.
Although tau is historically considered an axonal protein, recent studies indicate that tau can be present at the dendritic spine, either to play a physiological role or as a result of pathological missorting, and may contribute to degeneration of dendritic spines (Hoover et al., 2010; Ittner et al., 2010; Kremer et al., 2011; Tai et al., 2012; . To confirm the presence of tau at dendritic spines, the rTg4510-YFP mice were processed for array tomography studies (Fig. 7) . Staining human tau and YFP showed localization of human tau (HT7) and hyperphosphorylated tau (PHF1) at a subset of dendritic spines on pyramidal neurons, indicating that the presence of tau at spines may, in fact, contribute to their collapse.
Biochemical analyses suggest loss of function in synapses of rTg4510
Several studies have suggested that alterations to tau, such as hyperphosphorylation, mislocalization, or overexpression, induce toxicity by diminishing functionality of synapses rather than causing their overt loss (Polydoro et al., 2009; Hoover et al., 2010) . To assess the levels of synaptic proteins in remaining synapses of the rTg4510 mouse brain at an advanced age (12 months), biochemical fractionation of the brains was carried out to isolate synaptosomes , which were probed by western blot for functional components of the dendritic spine Figure 6 . Decreased dendritic spine density in the intact living rTg4510-YFP brain. In vivo multiphoton images of linear dendritic spine density of YFP-filled dendrites of littermate control (A) and rTg4510 (B) brains. Dendrites and associated spines were isolated from background for easier viewing. Bar graph in (C) shows quantification of linear spine density and one-way ANOVA demonstrates significant loss of spine density in aged rTg4510 mice (P < 0.0001). Graph shows means and standard deviations. Scale bar ¼ 2 lm. Figure 7 . Human tau in dendritic spines of rTg4510-YFP mice. Postmortem analysis of array tomography stacks (A) stained with phosphorylated tau (PHF1) shows neurofibrillary tangles and neuropil threads (tau aggregation in neurites) in a subset of both YFP-positive and YFP-negative neurons (3D reconstruction of 100 serial sections of 100 nm thickness 143 Â 143 Â 10 lm volume). Staining with both PHF1 (B) and total human tau (HT7; C) antibodies shows tau staining in a subset of dendritic spines (arrows, maximum intensity projections of three 100-nm sections). Scale bar ¼ 5 lm.
( Fig. 8 ). NMDA and AMPA receptors, generally anchored in the postsynaptic density (PSD95), are thought to subserve the processes underlying learning and memory through their presence and function. Loss of functional subunits (NMDAR1, NMDAR2A, GluR1, GluR2) would indicate a deficit or alteration in synaptic function. In 12-month-old rTg4510 mice, levels of PSD95, Synapsin I, NMDAR1, and GluR1 are all significantly decreased (P < 0.05 for all), while NMDAR2A and GluR2 expression do not demonstrate a deficit. These data suggest a preferential change to the constitution of pre-and postsynaptic elements, along with NMDA and AMPA receptors, and imply a potential loss of function in remaining synapses of rTg4510 mice. These data support electrophysiological findings in rTg4510 and other tau models, which demonstrate synaptic functional impairments due to tau overexpression (Polydoro et al., 2009; Rocher et al., 2010; Sydow et al., 2011b) .
DISCUSSION
Degeneration of synapses is a strong correlate of cognitive decline in AD brain, even more closely related to severity and progression of disease than the hallmark NFTs, extracellular amyloid plaques, and neuronal loss (Terry et al., 1991; Arriagada et al., 1992; DeKosky et al., 1996; Gomez-Isla et al., 1997; Giannakopoulos et al., 2003; Coleman and Yao, 2003) . Although the amyloid cascade hypothesis posits that disease pathogenesis is initiated by Ab with downstream consequences executed by the necessary presence of tau, it remains unclear how Ab and or tau may cause synaptic decay. The synapse, however, has been proposed as a point of convergence for both Ab and tau toxicity (Ittner et al., 2010; Roberson et al., 2011) . Previous studies linking tau and synapses have had complicated results, with some studies indicating distinct dendritic spine loss or dysfunction (Yoshiyama et al., 2007; Eckermann et al., 2007; Mocanu et al., 2008; Polydoro et al., 2009; Bittner et al., 2010; Rocher et al., 2010; Sydow et al., 2011b; Crimins et al., 2011) , others indicating no significant alteration in synapse density or function (Shahani et al., 2006; Tackenberg and Brandt, 2009; Hoover et al., 2010; Kimura et al., 2010 ) and a last set of studies suggesting compensatory increases in synapse density or function (David et al., 2005; Boekhoorn et al., 2006; Amadoro et al., 2010; Dickstein et al., 2010; Kimura et al., 2010; Kremer et al., 2011; Crimins et al., 2011) . Here we used two high-resolution imaging techniques to resolve some of these conflicting data in the rTg4510 model. We find preservation of overall synapse density in the neuropil even in the context of significant dendritic spine loss along apical dendrites of cortical pyramidal neurons, suggesting these neurons may be particularly vulnerable to tau-induced dendritic spine collapse, and furthermore indicating a compensatory response of other populations of synapses.
Assessment of synaptic structural and functional components in remaining synaptosomes from aged rTg4510 mice revealed reductions in synapsin I and PSD95 along with components of NMDA and AMPA receptors, NMDAR1 and GluR1, while two other constituents of these receptors (NMDAR2A and GluR2) remained stable. Figure 8 . Loss of functional components of remaining synapses in rTg4510 brain. Synaptosomes were isolated from the brains of aged rTg4510 and littermate control mice and probed by western blot (shown on the left) for functional components of the synapse. Quantification of the average of three trials is shown in the bar graphs to the right. PSD95, Synapsin I, NDMAR1, and GluR1 levels are significantly decreased in remaining synapses of rTg4510 mouse brain when compared to littermate controls, while NMDAR2A and GluR2 levels are maintained (*P < 0.05). Representative bands shown are from different locations on the same blot. Graphs show means and standard deviations.
These synaptic components are critical to neuronal function and dysregulation of individual elements suggests likely coincident synaptic dysfunction. Taken together, our data argue that synapse loss and dysfunction occur in rTg4510 mice.
Since distinguishing individual synapses is beyond the limits of routine light microscopy methods, we applied array tomography, a recently developed high-resolution immunohistochemical technique for localization and quantification of presynaptic and postsynaptic elements (Micheva and Smith, 2007; Micheva et al., 2010) . We have previously used this technique to show synapse loss associated with oligomeric Ab in both mouse models and human AD brain (Koffie et al., 2009 (Koffie et al., , 2012 . In this study we used array tomography to probe the role of tau in synaptic degeneration in rTg4510 mice. Somatosensory cortex of mice at an age prior to significant neuronal loss (5.5 months) and following significant neuronal loss (8.5 months) was prepared for array tomography and stained with reliable synaptic markers Synapsin I and PSD95 (Micheva et al., 2010) . Quantification with a thresholdbased automated program and manual physical disector stereology to confirm the validity of our automated analysis technique showed little evidence of change in synaptic density across either age group of rTg4510 mice when compared to littermate controls. The comparison of automated and manual analysis of array tomography stacks indicates that automated, threshold-based analysis, which is much less time-and labor-intensive, is adequate for comparisons of groups if the difference between groups is large enough (more than 10%), as we observed previously in examining synapse loss near plaques (Koffie et al., 2009 (Koffie et al., , 2012 . For more subtle differences, manual stereology or new nonthreshold-based automated image analysis methods may be more appropriate. Another advantage, however, of automated analysis is the ability to extrapolate additional data from the same set of raw images such as analysis of colocalization or proximity of different channels.
The maintenance of synaptic density in the neuropil along with the known cortical atrophy in this model by 8.5 months of age (Spires et al., 2006) indicates loss of synapses in parallel with cortical atrophy. An $30% deficit in linear dendritic spine density was observed using in vivo imaging of the aged rTg4510-YFP brain in comparison to control animals. It should be noted that these rTg4510-YFP mice have an additional YFP transgene driven by the Thy1 promoter alongside the CaMKII derived overexpression of mutant tau. Both promoters drive expression in pyramidal neurons of the forebrain, thereby generating high likelihood of double-expression, although this is, of course, not a guarantee. Furthermore, the use of separate promoters suggests expression of both transgenes without interference and yields no evidence in delay of degenerative processes as a result of YFP introduction. Our findings in the rTg4510-YFP mice are consistent with $30% dendritic spine loss observed in virus-filled neurons in 9-month rTg4510 mice (data not shown), and data from Rocher et al. (2010) , in which a 30-40% deficit of dendritic spines was identified in biocytin-filled neurons of 8.5-month-old rTg4510 mice and electron microscopy data from Mocanu et al. (2008) demonstrating an $30% loss of spine-synapses in tau transgenic mice expressing a proaggregant form of tau. The similarity across datasets indicates that YFP expression in rTg4510 mice does not interfere with the timeline of degenerative events.
Both the maintenance of synapse density as measured by array tomography and loss of linear spine density by in vivo imaging in the context of cortical atrophy demonstrate that tau overexpression results in synapse degeneration. Furthermore, pyramidal neurons may be particularly vulnerable to such decay, potentially resulting in compensatory responses from remaining neurons, with increases in other synapses, to augment network function. In support of this idea, Crimins et al. (2011) found an increase in filopodia (which are difficult to detect with in vivo imaging resolution) and electrophysiological evidence of synaptic compensation in aged rTg4510 mice. In addition, neuronal cultures exposed to Ab treatment have also demonstrated similar increases in filopodia (Wu et al., 2012) , suggesting a potential common mechanism of synaptic response to both Ab and tau. Such filopodia have been shown to have variable number of postsynaptic densities, ranging from zero to multiples (Petrak et al., 2005; Crimins et al., 2011) and may therefore be associated with delocalization of PSD95 and destabilization of dendritic spines. A recent study on mechanisms of Ab and tau toxicity to synapses and dendritic spines in neuronal cultures observed a shift of PSD95 from the synapse to the dendritic shaft . Changes like these have also been seen in the aging nonhuman primate brain (Dumitriu et al., 2010) and could be exacerbated in an age-related disease such as AD and suggest a second synaptic subtype that may be increased by compensatory responses in remaining neurons of rTg4510 brain.
Redistribution or mislocalization of PSD95, which serves as a scaffold for essential postsynaptic elements such as NMDA and AMPA receptors, may have negative ramifications for their localization or function as well (Hoover et al., 2010; Chakroborty and Stutzmann, 2011; D'Amelio et al., 2011; Huang and Mucke, 2012) . Our data indicate a significant loss of PSD95, synapsin, and subunits NMDAR1 and GluR1 of NMDA and AMPA receptors, respectively, while NMDAR2A and GluR2 levels are maintained in synaptosomes of aged rTg4510 mice. These data are consistent with findings in neuronal cultures overexpressing P301L tau, in which deficits were detected in NMDAR1, GluR1 but also in GluR2/3 levels (Hoover et al., 2010) . Human AD brain also exhibits preferential loss of NMDAR1 subunits while NMDAR2A levels remain stable (Bezprozvanny and Mattson, 2008) , which we also observe in the rTg4510 mouse brain. These data argue that pathological changes in tau may influence synaptic make-up and function in human AD brain as well as in tauopathy models. One of the mechanisms responsible for removal of synaptic receptors, known as long-term depression, is thought to be more efficient in disease models (D'Amelio et al., 2011) and may lead to an increase in silent synapses or dendritic spine collapse (Hoover et al., 2010) . Recent studies that place tau both physiologically and pathologically within the dendritic spine rather than solely in the axonal compartment indicate that tau may play a more direct role than previously believed in regulating the presence and function of postsynaptic receptors (Hoover et al., 2010; Ittner et al., 2010; Tai et al., 2012) . Here we demonstrate by array tomography that tau is present at dendritic spines and may therefore be implicated in the process of receptor subunit loss, thereby contributing to synaptic dysfunction and degradation. However, the presence of misfolded aggregates of tau as detected by the Alz50 antibody does not exacerbate local linear synapse density loss, suggesting that aggregates themselves may not enhance spine degradation.
Taken together, our data indicate dendritic spine loss and alterations in receptor constitution in aged rTg4510 mice with concomitant maintenance of synapse density, suggesting the possibility that compensatory responses or homeostatic mechanisms may counteract loss of dendritic spines.
